Navigation Links
Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results
Date:12/4/2008

TUSTIN, Calif., Dec. 4/PRNewswire-FirstCall/ --Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it will release its financial results for the second quarter of fiscal year 2009 on December 10, 2008 at 7:00 a.m. EST and will host a conference call and webcast to discuss the results at 11:30 a.m. EST on the same day.

Peregrine's senior management will discuss financial results for the second quarter ended October 31, 2008 and will review recent operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the archived webcast.

The conference call and webcast will begin at 11:30 a.m. EST/ 8:30 a.m. PST.

To listen to a live broadcast of the call over the Internet or to review the archived webcast, please visit: http://www.peregrineinc.com. The webcast will be archived on Peregrine's website for 30 days.

To listen to the conference call via telephone, please call the following number approximately 10 minutes prior to the scheduled start time and request to join the Peregrine Pharmaceuticals call: (800) 860-2442. A telephonic replay of the conference call will be available starting approximately one hour after the conclusion of the call through December 17, 2008 by calling (877) 344-7529, passcode 382933#.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead produc
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
3. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
4. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
6. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
8. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
9. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Wound Management Technol...ntered into a Letter of Intent to purchase all hea...ies, Inc. (OTC Bulletin Board: VHGI). The deal pro...ebt, 4,000,000 shares of WNDM and a royalty agreem...p technology being acquired from VHGI. WNDM clos...
(Date:11/5/2009)...RNewswire-FirstCall/ -- WaferGen Biosystems, Inc. ... state-of-the-art genetic analysis systems, today ... the company,s Scientific Advisory Board. His car...ing novel molecular diagnostics for cancer detecti...of computational biology systems for several biote...
(Date:11/5/2009)... Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunston...the "Company") today announced,that the Company pl...s on,Monday, November 9, 2009, after the market cl...e call at 5:00 pm ET on November 9, 2009,to discus...s the call by,dialing 1-888-713-4211 or 1-617-213-...
(Date:11/5/2009)...Surgery and vision correction experts listed in th...nvolved at the recently concluded American Academy... Francisco, California. Dr. Stephen Brint, MD, Dr.... MD, Dr. Peter Rapoza, MD, Dr. Michael Raizman, MD... Dr. Edward Manche, MD, and Dr. Parag Majmudar, MD...
Breaking Biology Technology:OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
... Disease, a serious, hereditary ...IA, Pa., Dec. 19 CSL Behring today,announced that...MOHME) has,granted rights to the company to distri... Iran, beginning immediately. Haemate P is indicat...serious, hereditary, and,sometimes life-threatenin...
...nding of Disease and Clear Path for ...d PHOENIX, Dec. 19 The,Banner Alzheimer,s Institu...hat they will collaborate to help advance understa...e of potential new avenues for treatment,through t...e new alliance will focus on the evaluation and fu...
...Amex:,ADL), today announced that its subsidiary, J..., and marketer of pharmaceutical, nutraceutical,di...oducts, is set to open,its first large-scale JPGre...na. The state-of-the-art facility was acquired by ...h and Personal Care Center., Customers will exper...
Other Biology Technology:CSL Behring Expands Into Middle East Market with Haemate(R) P 2CSL Behring Expands Into Middle East Market with Haemate(R) P 3AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease 2AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease 3AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease 4AMDL's First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China 2
(Date:11/4/2009)...re/ -- GenVault Corporation (Carlsbad, CA) today a...ed its Board of Directors. Dr. Brody, the Irwin J... an acclaimed physician-scientist and university l...rody served as president of The Johns Hopkins Univ... Engineering and the Institute of Medicine, and is...
(Date:11/3/2009)... For more than 25 years, all attempts at culturin...ave been unsuccessfuluntil now. For the first time...uce beaded (nucleated) and non-beaded cultured pea...ientists from Florida Atlantic University,s Harbor...than two years of research and experimentation, Dr...
(Date:11/3/2009)...ruit and vegetables is a new, patented technology ... used to label, or "etch" information on produce, ...pe labels. The technology has been licensed for us...ng used in New Zealand, Australia, and Pacific Rim...th Africa, Central and South America, Canada, and ...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Laser etching safe alternative for labeling grapefruit 2President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 1President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 2Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 1Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 2Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 3Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 4Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 5Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 6Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 7Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 8Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 9Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 10Cardium Reports Non Healing Wounds Continue to Challenge Patients and Healthcare Providers 4907 11Panel assesses evidence for the collection and use of family health history information 55523 1Panel assesses evidence for the collection and use of family health history information 55523 2Panel assesses evidence for the collection and use of family health history information 55523 3
...ed and compared the genomes of planktonic microbes... Ocean. The pioneering study yielded insight into ...h depth--ranging from 40 to more than 13,000 feet....es of entire microbial communities, we can begin t...d MIT,s Ed DeLong, who led the research team. "The...
... trial demonstrate that high doses of an experimen... responses in healthy adults. , Approximately hal...a booster dose of the highest dosage of the vaccin...n-fighting antibodies that current tests predict w...of Allergy and Infectious Diseases (NIAID), part o...
...transformation from a benign lifestyle in the soil... just a breath away. , Inhaled into the lungs of ...molds found around the world encounter a new, warm...ly shift gears and assume the guise of pathogenic ...fflictions as blastomycosis and histoplasmosis. ,...
Other Biology News:Wyoming cloud seeding experiment begins this month 2Wyoming cloud seeding experiment begins this month 3H5N1 avian flu virus vaccine induces immune responses in healthy adults 2H5N1 avian flu virus vaccine induces immune responses in healthy adults 3Wisconsin scientists discover a master key to microbes' pathogenic lifestyles 2Wisconsin scientists discover a master key to microbes' pathogenic lifestyles 3
... SYBR Green, TaqMan, LNA spiked TaqMan, MethyLight...specific primers are designed by avoiding cross ho... search results. Primer efficiency is enhanced by ...by connecting to the Mfold server. Beacon Designer...
Goat Anti-Human IL-17D Polyclonal Antibody, Unconjugated from R&D Systems
...-ADP, FHS-LVF and CVD-Diffuse We've combined our ...lters to create the world's first notch filter wit...andpass. Each filter features an excellent transmi...e filters -- with interference coatings applied to...
Agar - ULTRAPURE from GE Healthcare, formerly Amersham Biosciences
Biology Products: